MedPath

Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT Angiography

Completed
Conditions
Coronary Artery Disease
Registration Number
NCT02011061
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

Coronary calcium hampers accurate evaluation of the coronary arteries with coronary computed tomography angiography (CCTA). A novel approach to potentially overcome this limitation is coronary calcium subtraction.

The primary hypothesis of the study is:

- Coronary calcium subtraction CCTA will improve diagnostic accuracy as compared to conventional CCTA on a per-patient basis

Detailed Description

CCTA is a very important clinical method for the clinical evaluation of patients with chest pain of potential cardiac ischemic origin. However Coronary calcification and/or previously implanted coronary stents may limit the diagnostic accuracy of CCTA. A novel approach - coronary calcium subtraction - has been developed to potentially overcome this limitation.

* Study Objective: To assess diagnostic accuracy using coronary calcium subtraction coronary CT angiography (CCTA) as compared to conventional CCTA.

* Material and Methods: A total of 200 patients with suspected or known coronary artery disease (CAD) who have been referred for invasive coronary angiography (ICA) will prior to ICA undergo additional research CCTA with the newly developed coronary calcium subtraction protocol. Based on the coronary calcium scan (CS), coronary calcium score will be calculated according to the Agatston score. Conventional contrast enhanced CCTA studies will be analyzed for image quality and the presence and extent of coronary stenosis. Using a dedicated algorithm, subtraction will be performed on all datasets to obtain CCTA subtraction images. Subtracted images will be analyzed similar to the conventional CCTA images. ICA will serve as the gold standard. Image quality will be compared between conventional and subtracted CCTA. In addition, diagnostic accuracy in the evaluation of coronary stenosis as determined on ICA will be compared. Finally, factors influencing the performance of coronary calcium subtraction will be evaluated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
182
Inclusion Criteria
  • Age > 55 Years
  • Scheduled for invasive coronary angiography
  • Logistically possible to perform CCTA before invasive evaluation
Exclusion Criteria
  • Known Iodine-contrast allergy
  • Estimated GFR below 50 ml/min
  • Atrial fibrillation or other persistence cardiac arrythmia
  • Contraindication to betablockers (bronchospasm, LVEF less than 40%)
  • Implanted PM or ICD
  • Previous mechanical heart valve surgery
  • Inability to maintain breath-hold for at least 5 sec
  • Patient-related condition resulting the inability of the patient to understand the informed consent form of the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic accuracy of Coronary Subtraction Coronary CT angiographyWithin 90 days of ICA and CCTA

Sensitivity, Specificity, Negative and Positive predictive value of Coronary Subtraction CT angiography by visual assessment to identify a \>50% coronary stenosis as defined by invasive coronary angiography on a patient by patient level.

Secondary Outcome Measures
NameTimeMethod
Coronary CT angiography reader confidenceWithin 90 days of ICA and CCTA

Coronary CT angiography reader confidence by a 3 level visual scale assessed on CT images without and with Coronary Calcium Subtraction

Coronary stenosis severity in non-diagnostic or partially diagnostic segments by conventional CCTAWithin 90 days of ICA and CCTA

In coronary segments deemed non-diagnostic or partially diagnostic due to calcification or coronary stents by conventional CCTA concordance of stenosis severity by Coronary Subtraction CT angiography and invasive quantitative coronary angiography is assessed

Coronary revascularizationWithin 30 days after CCTA

On a patient by patient level the ability of CCTA to predict need for coronary revascularization (PCI or CABG) is assessed using CCTA without and with coronary calcium subtraction

Trial Locations

Locations (2)

Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen

🇩🇰

Copenhagen, Denmark

National Heart, Lung and Blood Institute

🇺🇸

Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath